Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., Broyde, A., Polachek, A., Wollman, J., Litinsky, I., Meridor, K., Nochomovitz, H., Silberman, A., Rosenberg, D., Feld, J., Haddad, A., Gazzit, T., Elias, M., Higazi, N., Kharouf, F., Shefer, G., Sharon, O., Pel, S., Nevo, S., & Elkayam, O. (2021). immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330–1338. http://access.bl.uk/ark:/81055/vdc_100180908862.0x000056